Monoclonal Antibody Production The Report and Recommendations of ECVAM Workshop 231

This is the report of the twenty-third of a series of workshops organised by the European Centre for the Validation of Alternative Methods (ECVAM). ECVAM’s main goal, as defined in 1993 by its Scientific Advisory Committee, is to promote the scientific and regulatory acceptance of alternative methods which are of importance to the biosciences and which reduce, refine or replace the use of laboratory animals. One of the first priorities set by ECVAM was the implementation of procedures which would enable it to become well-informed about the state-of-the-art of non-animal test development and validation, and the potential for the possible incorporation of alternative tests into regulatory procedures. It was decided that this would be best achieved by the organisation of ECVAM workshops on specific topics, at which small groups of invited experts would review the current status of various types of in vitro tests and their potential uses, and make recommendations about the best ways forward (1). The workshop on Monoclonal Antibody Production was held in Angera, Italy, on 19–22 November 1996, under the chairmanship of Uwe Marx (University of Leipzig, Monoclonal Antibody Production

[1]  W. Teo,et al.  Enhanced IgG production in eRDF media with and without serum. A comparative study. , 1994, Journal of immunological methods.

[2]  I. Marison,et al.  Effects of culture conditions on the production and quality of monoclonal IgA , 1997 .

[3]  T. Logtenberg,et al.  New perspectives on recombinant human antibodies. , 1996, Immunology today.

[4]  U von Stockar,et al.  Systematic improvement of a chemically-defined protein-free medium for hybridoma growth and monoclonal antibody production. , 1996, Journal of Biotechnology.

[5]  L. Trudel,et al.  Evaluation of hollow fiber bioreactors as an alternative to murine ascites production for small scale monoclonal antibody production. , 1996, Journal of immunological methods.

[6]  G. Winter,et al.  Making antibodies by phage display technology. , 1994, Annual review of immunology.

[7]  D R Burton,et al.  Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human monocyte Fc receptor. , 1985, Molecular immunology.

[8]  U. Marx,et al.  Glycosylation analysis of a polyreactive human monoclonal IgG antibody derived from a human-mouse heterohybridoma. , 1995, Molecular immunology.

[9]  A. Mizrahi Primatone RL in mammalian cell culture media. , 1977, Biotechnology and bioengineering.

[10]  R. Dwek,et al.  Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG , 1985, Nature.

[11]  Andrew N. Rowan,et al.  Refinement of Monoclonal Antibody Production and Animal Well-being , 1989 .

[12]  J Kovár,et al.  Serum-free medium for hybridoma and parental myeloma cell cultivation: a novel composition of growth-supporting substances. , 1984, Immunology letters.

[13]  H. Koprowski,et al.  Production of monoclonal antibodies in serum free medium. , 1980, Journal of immunological methods.

[14]  E. Shacter Serum-free media for bulk culture of hybridoma cells and the preparation of monoclonal antibodies , 1989 .

[15]  A. Rowan The Third R: Refinement , 1995, Alternatives to laboratory animals : ATLA.

[16]  J. Fox,et al.  Institutional Policies and Guidelines on Adjuvants and Antibody Production. , 1995, ILAR journal.

[17]  C. Hendriksen,et al.  The Production of Monoclonal Antibodies: Are Animals Still Needed? , 1996 .

[18]  S. Reuveny,et al.  Kinetics of monoclonal antibody production in low serum growth medium. , 1986, Journal of immunological methods.

[19]  D R Burton,et al.  Human antibodies from combinatorial libraries. , 1994, Advances in immunology.

[20]  G. Hewlett Strategies for optimising serum-free media , 2004, Cytotechnology (Dordrecht).

[21]  I. Ruhdel,et al.  Monoclonal Antibodies: In Vivo and In Vitro Production on a Laboratory Scale, with Consideration of the Legal Aspects of Animal Protection , 1989, ALTEX.

[22]  I. Marison,et al.  Production of immunoglobulin A in different reactor configurations , 1995, Cytotechnology.

[23]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[24]  Horst Spielmann,et al.  The Production of Avian (Egg Yolk) Antibodies: IgY , 1996 .